Advancing small molecules from R&D to GMP requires coordinated strategies to support phase I clinical manufacturing.

The investment brings the company's total Indiana capital expansion commitments since 2020 to more than $21 billion.

Why does product loss occur in aseptic fill-finish, and how can a CDMO overcome material constraints to preserve as much drug product as possible?

Lilly’s latest commitment at the LEAP District brings the company’s total investment there since 2022 to $18 billion.

Dr. Gonzalez will bring valuable manufacturing and regulatory expertise to Khona Scientific as it expands production of ...

In a significant step up from a largely domestic industrial player to a contender in the global oil and gas supply chain, ...

Ahead of the election, the Southern California News Group compiled a list of questions to pose to the candidates vying to ...

Thank you for standing by. My name is Kathleen, and I will be your conference operator today. At this time, I would like to welcome everyone to the First Quarter 2026 NCR Voyix Corporation Earnings ...

Flotek Industries, Inc. ( FTK) Q1 2026 Earnings Call May 6, 2026 10:00 AM EDT Good morning, ladies and gentlemen, and welcome to the Flotek First Quarter 2026 Earnings Conference Call. [Operator ...

A lot happened in India’s startup ecosystem in April. As tensions in West Asia dragged on, funding activity at home slowed ...

With the acquisition, Siegfried adds three high-quality small-molecule drug substances sites to its global drug substances ...

If you work in HR, people ops, or talent management, you've probably noticed the same thing everyone else has: there are a ...